Dr. Jessica Clement, Medical Oncologist, Joins Cancer Institute in Manchester

Dr. Jessica Clement
Print icon

Dr. Jessica Clement has joined the team of the Hartford HealthCare Cancer Institute as a medical oncologist. She will see patients at the new Hartford HealthCare location in Manchester starting March 25.

Dr. Clement’s arrival is timed with the opening of a three-story medical facility in Manchester as part of the Cancer Institute’s plan to bring advanced oncology care close to home for people east of Hartford. The facility features a bright, airy infusion center, a rooftop patio for patients and families, a dedicated pharmacy and space for a variety of oncology specialists like Dr. Clement to see patients.

She will join other medical oncologists in Manchester. Also seeing patients there is Dr. Patricia DeFusco, the system-wide director of the Cancer Institute’s Breast Program, and Dr. Heather King, director of Breast Services in the Hartford region.

Dr. Clement has worked in Central Connecticut since 2010 at UConn Health. She graduated magna cum laude from Union College, where she earned a bachelor’s degree in biology, and then earned a medical degree from the Medical College of Virginia/Virginia Commonwealth University. She completed an internship and residency in medicine through Harvard Medical School at Beth Israel Deaconess Medical Center, where she was chief medical resident the final year. She also completed a clinical and research fellowship in hematology-oncology at Beth Israel Deaconess.

Dr. Clement is a prolific and enthusiastic researcher, having authored numerous articles in professional journals on the efficacy of various treatments for prostate, bladder and esophageal cancers, as well as the safe delivery of intra-cerebral spinal fluid chemotherapy and the impact of a pharmacist-led chemotherapy monitoring program for some prostate cancer patients. She has presented around the country on such topics as immune checkpoint inhibitors in genitourinary malignancies and the evolving treatment paradigm for oligometastatic prostate cancer patients.

Board-certified in internal medicine with subspecialty certification in hematology and medical oncology, Dr. Clement’s current research interests include immunotherapy in bladder cancer and researching other novel therapies. Her efforts as a clinician and researcher have earned her national attention. In 2017, she was named a fellow of the Association of American Medical Colleges Leadership Education and Development Certificate Program in the Northeast Group on Educational Affairs Cohort, and received Top Doc recognition from Connecticut Magazine for oncology/hematology.

Dr. Jessica Clement will be accepting patients at 376 Tolland Turnpike, Suite 201 in Manchester. Appointments can be made by calling 860.533.5830.


What's New

Cancer Recovery and Physical Activiity

The Importance of Physical Activity in Cancer Survivorship

By Gretchin Bade Program Director of Oncology Hartford Hospital Rehabilitation Network At least 20 studies of people with breast, colorectal, prostate and ovarian cancer have suggested that physically active cancer survivors have a lower risk of cancer recurrence and improved survival compared to survivors who are inactive. Exercise also has...

Colorectal Cancer

Rebuilding Your Life After Colorectal Cancer Diagnosis

Dr. Gerard Fumo Physician Lead, Hartford HealthCare Gastrointestinal Disease Management Team Colorectal cancer, a potentially lethal disease, is one of the most preventable cancers because doctors can remove precancerous growths during a colonoscopy. In part, because of the advances in screening, which leads to detection and removal of early cancers,...


Windham Hospital Foundation to Host Cancer Survivors Day Luncheon June 8

Windham Hospital’s Annual Cancer Survivors Day Luncheon is Saturday June 8,Noon to 2 pm in the Betty Tipton Room at Eastern Connecticut State University, 5 Charter Oak Road, Willimantic. The event, hosted by the Hartford HealthCare Cancer Institute at Windham Hospital and the Windham Hospital Foundation, will include several guest speakers, a buffet and a...

Breast Screening

Breast Surgeons Group: Start Routine Screening at Age 40

If age is just a number, why is the year a woman should start having annual mammograms so important – and so controversial? Most recently, the American Society of Breast Surgeons (ASBrS) issued new guidelines advising women at average risk of breast cancer to begin annual mammograms at 40, which...

Cure Award

Cancer Institute’s Abbi Bruce an Extraordinary Healer Award Finalist

Abbi Bruce, director of the Hartford Region of the Hartford HealthCare Cancer Institute, has been recognized as a finalist for the CURE 2019 Extraordinary Healer Award. This is a distinguished national award presented at the Oncology Nursing Society annual conference to honor oncology nurses who have made great strides in...